FNDC5 and prostate carcinoma: Investigation with PC-3 metastatic prostate cancer cells revealed that exogenous irisin reduced cell viability, while tumor growth and progression were reduced in vivo, suggesting that apoptotic pathways were enhanced by irisin (91).